NCT01928641

Brief Summary

Intravenous tissue plasminogen activator (IV t-PA) is the only proven treatment of hyperacute cerebral infarction. The outcome of this treatment highly depends on the time from symptom onset to the administration of thrombolytic agent. Last known normal time is widely used as the standard to determine the symptom onset. These stroke symptoms are usually caused by a sudden decrease in cerebral blood flow related with an embolic or thrombotic event. However, in some cases various symptoms may occur one after another. Myocardial infarction is also caused by a sudden caseation of blood flow. The symptom of myocardial infarction usually contains chest pain, and it is easy to identify the exact time of onset. In contrast, cerebral infarction may cause various symptoms according to the infarcted area of the brain, and sometimes multiple symptoms are presented in rapid succession. Therefore, it may be much unclear and uncertain to determine the onset time of cerebral infarction. Despite the importance of onset time in therapeutic decision making, there was no study focusing on the certainty of onset time in cerebral infarction patients. In this study, we will investigate the subjective certainty of patient about the onset time in clear-onset cerebral ischemia. The discrepancy in diagnosing the onset time will be analyzed among the clinicians involved in the practice. Then, the factors associated with this uncertainty will be verified.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

August 11, 2013

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 27, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

January 16, 2019

Status Verified

January 1, 2019

Enrollment Period

10 months

First QC Date

August 11, 2013

Last Update Submit

January 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Discrepancy (difference) in the time onset of stroke symptoms diagnosed by two different neurologists

    The onset time assessed at emergency departement by a neurologist will be compared to the onset time assessed next day after admission by a different neurologist.

    Onset time will be obtained two times,first at the visit time of emergency department (within 24 hours from onset) and secondly the day after admission (within 48 hours from onset)

Secondary Outcomes (2)

  • Factors influencing the subjective uncertainty of stroke symptom onset by patients

    The subjective certainty will be obtained the day after admission (within 48 hours from onset)

  • Factor influencing the objective discrepancy of stroke symptom onset diagnosed by two different neurologists

    The factors will be obtained the day after admission (within 48 hours from symptom onset)

Study Arms (1)

Discrepancy in stroke onset

Patients with discrepancy in stroke symptom onset based on the diagnosis of the first neurologist who evaluated the patient at emergency room and the next day after admission

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Ischemic stroke patients admitted to Acute Stroke Unit at Asan Medical Center Patients older than 20 years old Symptom onset within 24 hours

You may qualify if:

  • ischemic stroke patients admitted to Acute Stroke Unit at Asan Medical Center
  • ischemic stroke patients older than 20 years old
  • symptom onset within 24 hours

You may not qualify if:

  • patients who cannot explain the symptom onset due to altered consciousness, aphasia, or cognitive decline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dong-Wha Kang

Seoul, 138-372, South Korea

Location

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Dong-Wha Kang, MD

    Department of Neurology, Asan Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 11, 2013

First Posted

August 27, 2013

Study Start

August 1, 2013

Primary Completion

June 1, 2014

Study Completion

August 1, 2014

Last Updated

January 16, 2019

Record last verified: 2019-01

Locations